Endless
Even Keel
- Messages
- 4,466
- Reaction score
- 3
- Points
- 0
Perampanel is a new treatment for partial seizures. The results of the Phase III clinical trials in Japan were very positive. An application for a marketing permit in Japan was just submitted by the manufacturer. There was no mention of plans yet for clinical trials or applications for marketing in the U.S. Here's hopes that it will be soon.
http://www.medicalnewstoday.com/articles/230115.php
Other epilepsy drugs on the way:
Potiga (ezogabine) Tablets Approved For Seizure In Adults As Add-On Medication
Info on Trobalt
New Drug Could Further Help People With Epilepsy
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy
Scottish Medicines Consortium Accepts Trobalt(R) (Retigabine) For Restricted Use As An Adjunctive Treatment Of Refractory Partial Onset Epilepsy
NICE Preliminary Guidance Recommends Trobalt® (retigabine) For Adjunctive Treatment Of Partial Onset Epilepsy
About Perampanel
Perampanel is a highly selective, non-competitive AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)-type glutamate receptor antagonist. It has exhibited anti-seizure effects in Phase II and III studies.
Nerve signals stimulated by the excitatory neurotransmitter glutamate within the brain are transmitted by AMPA receptors which are extensively present in excitatory neurons. These receptors are believed to play a significant role in all neurological illnesses characterized by excess neuroexcitatory signaling, such as epilepsy.
If approved by EMA or FDA, perampanel will be the first product in this class.
http://www.medicalnewstoday.com/articles/230115.php
Other epilepsy drugs on the way:
Potiga (ezogabine) Tablets Approved For Seizure In Adults As Add-On Medication
Info on Trobalt
New Drug Could Further Help People With Epilepsy
New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy
Scottish Medicines Consortium Accepts Trobalt(R) (Retigabine) For Restricted Use As An Adjunctive Treatment Of Refractory Partial Onset Epilepsy
NICE Preliminary Guidance Recommends Trobalt® (retigabine) For Adjunctive Treatment Of Partial Onset Epilepsy
Last edited: